chr5-90625135-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The NM_032119.4(ADGRV1):c.564G>T(p.Glu188Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000692 in 1,604,198 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Uncertain significancein ClinVar.
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADGRV1 | NM_032119.4 | c.564G>T | p.Glu188Asp | missense_variant | 6/90 | ENST00000405460.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADGRV1 | ENST00000405460.9 | c.564G>T | p.Glu188Asp | missense_variant | 6/90 | 1 | NM_032119.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000977 AC: 24AN: 245616Hom.: 0 AF XY: 0.0000676 AC XY: 9AN XY: 133048
GnomAD4 exome AF: 0.0000372 AC: 54AN: 1451922Hom.: 0 Cov.: 28 AF XY: 0.0000263 AC XY: 19AN XY: 722424
GnomAD4 genome AF: 0.000374 AC: 57AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 27AN XY: 74478
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 27, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 12, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.564G>T (p.E188D) alteration is located in exon 6 (coding exon 6) of the ADGRV1 gene. This alteration results from a G to T substitution at nucleotide position 564, causing the glutamic acid (E) at amino acid position 188 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at